Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GRASP-LGMD: Defining Clinical Endpoints in LGMD

NCT03981289 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT03981289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03981289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GRASP-LGMD: Defining Clinical Endpoints in LGMD
Lead sponsor
Virginia Commonwealth University
Phase
Observational
Overall status
Completed
Start date
June 14, 2019
Completion date
June 30, 2025
Enrollment
116 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

limb girdle muscular dystrophy, muscular dystrophies